Citadel Advisors
DMK

Citadel Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Citadel Advisors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-213
Closed -$1.73K – 15527
2023
Q1 		$1.73K Sell
213
-306
-59% -$4.06K ﹤0.01% 14254
2022
Q4 		$6.15K Sell
519
-115
-18% -$1.31K ﹤0.01% 13939
2022
Q3 		$9K Sell
634
-263
-29% -$6.79K ﹤0.01% 12301
2022
Q2 		$31K Buy
897
+34
+4% +$1.06K ﹤0.01% 12214
2022
Q1 		$34K Sell
863
-684
-44% -$29.4K ﹤0.01% 13042
2021
Q4 		$66K Sell
1,547
-687
-31% -$42.8K ﹤0.01% 13086
2021
Q3 		$152K Buy
2,234
+1,174
+111% +$85.9K ﹤0.01% 12367
2021
Q2 		$82K Sell
1,060
-121
-10% -$7.37K ﹤0.01% 13064
2021
Q1 		$78K Buy
+1,181
New +$92K ﹤0.01% 12661
2019
Q1 		– Sell
-154
Closed -$24K – 10041
2018
Q4 		$24K Sell
154
-600
-80% -$115K ﹤0.01% 8687
2018
Q3 		$185K Buy
754
+388
+106% +$91.9K ﹤0.01% 8266
2018
Q2 		$82K Buy
366
+17
+5% +$4.55K ﹤0.01% 8316
2018
Q1 		$85K Buy
+349
New +$91.6K ﹤0.01% 7770
2017
Q4 		– Sell
-210
Closed -$77K – 8553
2017
Q3 		$77K Sell
210
-84
-29% -$29.8K ﹤0.01% 7102
2017
Q2 		$107K Sell
294
-142
-33% -$42.5K ﹤0.01% 6879
2017
Q1 		$130K Buy
436
+236
+118% +$59.5K ﹤0.01% 6756
2016
Q4 		$44K Buy
+200
New +$40.1K ﹤0.01% 6895

Other funds holding DMK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Citadel Advisors's DMK Position: Q2 2023 in Review

Citadel Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 4,674 shares — an estimated $37.9K sold.

Citadel Advisors first reported a position in DMK in Q4 2016 and held it in 17 quarters. The position peaked at $384K in Q4 2017. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

  • Citadel Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 4,674 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $37.9K.
  • Citadel Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2016 and held it in 17 quarters.
  • Citadel Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $384K in Q4 2017.
  • 22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.